Responses to carboplatin in BRCA1/2-mutated breast cancer

被引：3
|
作者：
Burki, Talha Khan
机构：
来源：
LANCET ONCOLOGY | 2018年 / 19卷 / 07期
关键词：
D O I：
10.1016/S1470-2045(18)30407-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E337 / E337
页数：1
相关论文
共 50 条
  • [31] PD-1, PD-L1 in BRCA1/2-mutated and non-mutated epithelial ovarian carcinomas (EOCs).
    Sachdev, Jasgit C.
    Arguello, David
    Abbott, Brian L.
    Reddy, Sandeep K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] BRCA2 AND BRCA1 breast cancer phenotypes
    Marcus, JN
    Watson, P
    Page, DL
    Narod, SA
    Tonin, P
    Serova, O
    Lenoir, GM
    Lynch, HT
    LABORATORY INVESTIGATION, 1997, 76 (01) : 110 - 110
  • [33] BRCA1 and BRCA2 Mutations and Breast Cancer
    Narod, Steven A.
    Salmena, Leonardo
    DISCOVERY MEDICINE, 2011, 12 (66) : 445 - 453
  • [34] BRCA1 and BRCA2 in hereditary breast cancer
    Scully, R
    Puget, N
    BIOCHIMIE, 2002, 84 (01) : 95 - 102
  • [35] Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain
    Cedillo, Sergio
    Gonzalez-Dominguez, Almudena
    Ivanova-Markova, Yoana
    Lopez, Rafael Lopez
    Cobo, Sara Lopez-Tarruella
    Pedrosa, Jose Alberto Pena
    PHARMACOECONOMICS-OPEN, 2024, 8 (06) : 887 - 896
  • [36] Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer
    Garber, Haven R.
    Raghavendra, Akshara Singareeka
    Lehner, Michael
    Qiao, Wei
    Gutierrez-Barrera, Angelica M.
    Tripathy, Debu
    Arun, Banu
    Ibrahim, Nuhad K.
    NPJ BREAST CANCER, 2022, 8 (01)
  • [37] REAL WORLD OUTCOMES OF OLAPARIB MAINTENANCE THERAPY IN PATIENTS WITH BRCA1/2-MUTATED PLATINUM-SENSITIVE EPITHELIAL OVARIAN CANCER
    McLaren, A.
    White, M.
    Cartwright, D.
    Brown, J.
    Randhawa, M.
    Roxburgh, T.
    Glasspool, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A166 - A166
  • [38] MicroRNA profiling to identify novel determinants of platinum resistance in BRCA1/2-mutated high-grade serous ovarian cancer
    Meghani, Khyati
    Gogola, Ewa
    Rottenberg, Sven
    Jonkers, Jos
    Matulonis, Ursula
    Swisher, Elizabeth
    Konstantinopoulos, Panagiotis
    Chowdhury, Dipanjan
    CANCER RESEARCH, 2017, 77
  • [39] Clinical Impact and Genomic Features of Human Epidermal Growth Factor Receptor 2-Low Tumors in BRCA1/2-Mutated Triple-Negative Breast Cancer
    Kou, Furong
    Liu, Huimin
    Zhang, Yaxin
    Liao, Xingyu
    Hu, Li
    Sun, Jie
    Zhang, Juan
    Xu, Ye
    Yao, Lu
    Xie, Yuntao
    JCO PRECISION ONCOLOGY, 2025, 9
  • [40] Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer
    Haven R. Garber
    Akshara Singareeka Raghavendra
    Michael Lehner
    Wei Qiao
    Angelica M. Gutierrez-Barrera
    Debu Tripathy
    Banu Arun
    Nuhad K. Ibrahim
    npj Breast Cancer, 8
12345